1. Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). (31st October 2018) Authors: Kessler, David S; MacNeill, Stephanie J; Tallon, Deborah; Lewis, Glyn; Peters, Tim J; Hollingworth, William; Round, Jeff; Burns, Alison; Chew-Graham, Carolyn A; Anderson, Ian M; Shepherd, Tom; Campbell, John; Dickens, Chris M; Carter, Mary; Jenkinson, Caroline; Macleod, Una; Gibson, Helen; Davies... Journal: BMJ Issue: Volume 363(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗